Breaking News

Societal CDMO Adds Psychedelic Drug Development Capabilities

Secures Schedule 1 Controlled Substance Manufacturing License from Drug Enforcement Agency.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Societal CDMO, Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges, expanded its suite of CDMO services to address the biopharmaceutical industry’s expanding activity in the area of psychedelic drug development. This expansion of capabilities will support the growing number of ongoing and planned clinical trials in this area.   Societal has completed key regulatory requirements for this work and can support cu...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters